Bioventus (BVS) EPS (Basic) Growth (1y) (2022 - 2026)
Bioventus (BVS) EPS (Basic) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 13.85% |
| 10 | Bioventus | 970.53 Mn | 941.07 Mn | 105.67 Mn | 282.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 282.60% |
| Mar 28, 2026 | 216.51% |
| Apr 1, 2023 | -17,970.93% |
| Dec 31, 2022 | -69,220.06% |
| Oct 1, 2022 | -1,235.29% |
| Jul 2, 2022 | 98.23% |
| Apr 2, 2022 | -101.13% |